Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Insights

      Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million

      Insights
      Mallinckrodt plc , a global biopharmaceutical company, announced it has entered into a definitive agreement to sell its wholly owned subsidiary BioVectra Inc. to...

      Sonnet BioTherapeutics Announces Acquisition Agreement with Relief Therapeutics Holding SA for Atexakin Alpha

      Insights
      Sonnet BioTherapeutics, Inc., an oncology-focused biotechnology company developing innovative targeted biologic drugs, announced it has entered into an agreement with Relief Therapeutics Holding SA...

      Arena Reports Second Quarter Financial Results with Strong Liquidity Position and Olorinab CAPTIVATE Trials

      Insights
      Arena Pharmaceuticals, Inc. provided a corporate update and reported financial results for the second quarter ended June 30, 2019. "Arena is off to a strong...

      Glaukos and Avedro Announce Definitive Acquisition Agreement

      Insights
      Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, and...

      Vertex Pharmaceuticals to buy US firm Exonics Therapeutics

      Insights
      Vertex Pharmaceuticals has signed an agreement to acquire US-based Exonics Therapeutics in a deal valued up to $1bn (£787m). Under the deal, Exonics equity holders...

      Camargo to Acquire Montreal-based InSymbiosis

      Insights
      Camargo Pharmaceutical Services announced it will acquire InSymbiosis, a Canadian drug development partner which improves how biopharma companies outsource R&D. This announcement comes after Camargo...

      Dr Reddys Laboratories to sell neurology branded products to Upsher-Smith Laboratories

      Insights
      Under the agreement, Dr.Reddy’swill receive U.S.$70 million as upfront consideration, U.S.$40.5 million in near term milestones and additional financial considerations including, existing contractual obligation...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.